Tag Archives: Mayo Clinic

A nurse practitioner-directed intervention improves the quality of life of patients with metastatic cancer

May 23rd, 2012 - 1:23 pm

Gerardo Colon-Otero, M.D., with the Department of Hematology/Oncology at Mayo Clinic in Florida, discusses results of a randomized pilot study that show that an intervention that explains the benefits of hospice and addresses advanced directives early in the course of … Continue reading →

By Miriam Wuensch | Posted in Cancer | Tagged , , | Comments (6)

Clinical trials aid PSC diagnosis and treatment

May 2nd, 2012 - 9:25 am

Jayant A. Talwalkar, M.D., a hepatologist with the Department of Gastroenterology and Hepatology and the Mayo Clinic Transplant Center in Rochester, Minn., discusses diagnosis, complications, liver transplantation, and Mayo’s role in the development of new diagnostic tests and effective therapies for … Continue reading →

By Miriam Wuensch | Posted in Gastroenterology | Tagged , , , | Comments (7)

Distribution of arterial lesions in Takayasu’s arteritis

April 26th, 2012 - 11:29 am

Steven R. Ytterberg, M.D., with the Department of Rheumatology at Mayo Clinic in Rochester, Minn., discusses a study that examined similarities and differences between two forms of vasculitis: giant cell arteritis and Takayasu’s arteritis. Findings suggest that TAK and GCA … Continue reading →

By Miriam Wuensch | Posted in Rheumatology | Tagged , , , , , , | Comments (2)

Mayo Clinic study finds that cardiac rehab reduces mortality by 45 percent

April 3rd, 2012 - 8:10 pm

Randal J. Thomas, M.D., director of Mayo Clinic’s Cardiovascular Health Clinic, and colleagues found that patients who participate in cardiac rehabilitation after having heart interventions such as angioplasty, stents and clot-busting drugs have a 45 percent lower mortality rate. The … Continue reading →

By Nicole Engler | Posted in Cardiovascular | Tagged , , , | Comments (12)

Mayo Clinic study confirms stents are safe for patients allergic to metal

April 3rd, 2012 - 8:01 pm

Mayo Clinic researchers have found that cardiac patients who have skin allergies to metals commonly found in jewelry, such as nickel, are at no higher risk for complications if they receive a stent containing these metal components. Mayo Clinic cardiologist … Continue reading →

By Nicole Engler | Posted in Cardiovascular | Tagged , , | Comments (5)

Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes

March 22nd, 2012 - 11:47 am

Vanda A. Lennon, M.D., Ph.D., with the Departments of Laboratory Medicine and Pathology and Neurology, discusses research that identifies critical properties of neuromyelitis optica, a potentially debilitating neurological disease that is often misdiagnosed as multiple sclerosis (MS). Dr. Lennon’s team … Continue reading →

By Miriam Wuensch | Posted in Neurology | Tagged , , , , | Leave a comment

One thousand patients with primary myelofibrosis: The Mayo Clinic experience

March 15th, 2012 - 3:29 pm

Ayalew Tefferi, M.D., with the Department of Hematology at Mayo Clinic in Rochester, Minn., discusses the results of a study of 1,000 patients who have primary myelofibrosis. Key findings Researchers found that when patients with myelofibrosis present, their clinical features … Continue reading →

By Miriam Wuensch | Posted in Hematology | Tagged , | Comments (1)

An evaluation of safety and feasibility using rTMS in adolescents with depression

January 26th, 2012 - 3:40 pm

Christopher A. Wall, M.D., with the departments of Pediatric and Adolescent Medicine and Psychiatry and Psychology, discusses a study that suggests that repetitive transcranial magnetic stimulation (rTMS) is a safe, feasible, and potentially effective adjunctive therapy for treatment-resistant major depressive disorder (MDD) in … Continue reading →

By Miriam Wuensch | Posted in Psychiatry | Tagged , , , , , | Comments (1)

Comparison of age-related macular degeneration treatments trials: Lucentis-Avastin trial

January 18th, 2012 - 12:22 pm

Sophie J. Bakri, M.D., with the Department of Ophthalmology at Mayo Clinic in Rochester, Minn., and study principal investigator at Mayo Clinic, discusses first-year results from the National Eye Institute–funded study of neovascular age-related macular degeneration (AMD). Findings indicate that bevacizumab … Continue reading →

By Miriam Wuensch | Posted in Ophthalmology | Tagged , , , , , , , | Leave a comment

Inflammatory cortical demyelination in early multiple sclerosis

December 15th, 2011 - 3:31 pm

Claudia F. Lucchinetti, M.D. of the Department of Neurology at Mayo Clinic in Rochester, Minn., discusses a study that provides definitive evidence that inflammatory disease of the gray matter commences early in the pathogenesis of some cases of multiple sclerosis. An … Continue reading →

By Miriam Wuensch | Posted in Neurology | Tagged , , , | Leave a comment